IONIS-DGAT2Rx
- Generic Name
- IONIS-DGAT2Rx
A Study to Assess the Safety, Efficacy, and Pharmacokinetics of Multiple Doses of ION224
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT04932512
- Locations
- 🇺🇸
Excel Medical Clinical Trials, LLC, Boca Raton, Florida, United States
🇺🇸Covenant Metabolic Specialists, LLC, Sarasota, Florida, United States
🇺🇸Louisiana Research Center, LLC, Shreveport, Louisiana, United States
Safety, Tolerability, and Pharmacodynamics of IONIS-DGAT2Rx in Adult Patients With Type 2 Diabetes
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2020-01-27
- Lead Sponsor
- Ionis Pharmaceuticals, Inc.
- Target Recruit Count
- 44
- Registration Number
- NCT03334214
- Locations
- 🇬🇧
Ionis Investigational Site, Nottingham, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath